Your browser doesn't support javascript.
loading
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
Cree, Bruce Ac; Arnold, Douglas L; Fox, Robert J; Gold, Ralf; Vermersch, Patrick; Benedict, Ralph Hb; Bar-Or, Amit; Piani-Meier, Daniela; Rouyrre, Nicolas; Ritter, Shannon; Kilaru, Ajay; Karlsson, Goeril; Giovannoni, Gavin; Kappos, Ludwig.
Affiliation
  • Cree BA; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
  • Arnold DL; NeuroRx Research, and Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
  • Fox RJ; Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Gold R; Department of Neurology, St. Josef-Hospital and Ruhr-University Bochum, Bochum, Germany.
  • Vermersch P; Univ. Lille, INSERM U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.
  • Benedict RH; Department of Neurology, University at Buffalo, Buffalo, NY, USA.
  • Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Piani-Meier D; Novartis Pharma AG, Basel, Switzerland.
  • Rouyrre N; Novartis Pharma AG, Basel, Switzerland.
  • Ritter S; Novartis Pharma AG, Basel, Switzerland.
  • Kilaru A; Novartis Pharma AG, Basel, Switzerland.
  • Karlsson G; Novartis Pharma AG, Basel, Switzerland.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland.
Mult Scler ; 28(10): 1591-1605, 2022 09.
Article in En | MEDLINE | ID: mdl-35380078
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2022 Type: Article Affiliation country: United States